When was Altasciences founded?

Altasciences was founded in 2015.

Where is Altasciences located?

Altasciences is headquartered in Laval, Canada. It is registered at Everett, Washington.

Who is the current CEO of Altasciences?

Christopher Perkin of Altasciences.

How many employees does Altasciences have?

As of Apr 30, 2026, the latest employee count at Altasciences is 1.

Is Altasciences a funded company?

Altasciences is a funded company, having raised a total of $***** in its 1st and only funding round.

Where does Altasciences rank among its competitors?

Altasciences ranks 1st amongst 98 active competitors, of which 7 are funded. It stands 3rd in terms of total funding among its competitors. The most recent competitor to raise funding was MindBio Therapeutics, which secured an undisclosed amount in Apr, 2026.

Who are the top competitors of Altasciences?

Altasciences' top competitors include HMR London, Celerion and MindBio Therapeutics. Among them, MindBio Therapeutics secured the most recent funding round in April, 2026.

Altasciences - 2026 Company Profile, Team, Funding & Competitors

Altasciences is an acquired company based in Laval (Canada), founded in 2015. It operates as an Early phase CRO. The company has 98 active competitors, including 7 funded and 23 that have exited. Its top competitors include companies like HMR London, Celerion and MindBio Therapeutics.

Company Details

Altasciences Clinical Research is an early phase clinical research organisations (CRO) offering its services in North America. Altasciences Clinical Research encompasses Algorithme Pharma in Montreal, Canada, Vince & Associates Clinical Research in Overland Park, USA, as well as Algorithme Pharma USA in Fargo, ND. It conducts clinical trials in Phase I/IIa, bioequivalence, and bioanalysis (preclinical to Phase I-IV).

Website: www.altasciences.com/
Social
Email ID: *****@altasciences.com
Registered Address: Everett, Washington

Key Metrics

Founded Year

2015

Location

Laval, Canada

Stage

Acquired

Investors

Signet Healthcare Partners & 2 more

Ranked

1^st among 98 active competitors

Employee Count

1 as on Apr 30, 2026

Investment & Acquisitions

Sinclair Research & 6 more

Similar Companies

HMR London & 117 more

Exit Details

Acquired by Novo Holdings (Feb 22, 2021)

View Altasciences' full profile

Altasciences is associated with 2 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
ALTASCIENCES PRECLINICAL SEATTLE, LLC CIN: 831352782 , United States, Active		-	249 (As on Dec 31, 2020)	-
ALGORITHME PHARMA USA, LLC CIN: 383940620 , United States, Active		-	1 (As on Dec 31, 2018)	-

Altasciences got acquired by Novo Holdings on Feb 22, 2021.

Click here to take a look at Altasciences's acquisition in detail

Altasciences is a funded company. Altasciences has 3 institutional investors.

View details of Altasciences's funding rounds and investors

Altasciences' employee count trend

Altasciences has 1 employees as of Apr 26. Here is Altasciences's employee count trend over the years:

Uncover Altasciences' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Altasciences include HMR London, Celerion and MindBio Therapeutics. Here is the list of Top 10 competitors of Altasciences, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Altasciences 2015, Laval (Canada), Acquired	Early phase CRO	-	Signet Healthcare Partners, Apollo Investment Corporation ... & 1 others	52/100
2nd	HMR London 1993, London (United Kingdom), Acquired	Provider of early phase clinical research services for drug development	-	EIC Fund, Europa	51/100
3rd	Celerion 2010, Lincoln (United States), Acquired	Translational medicine experts accelerating drug development for global patient impact	-	Bain Capital Ventures, SV Health Investors ... & 3 others	51/100
4th	MindBio Therapeutics 2021, Melbourne (Australia), Public	Provider of phase I & II clinical trial services for mental health diseases	-	Blackhawk Growth Corp, Hardenbrook Group	48/100
5th	AWAKN 2020, Portishead (United Kingdom), Acquired	CRO focused on early stage clinical trial research	-	Palo Santo, Iter Investments	47/100
6th	BioPharma Services 2006, Toronto (Canada), Acquired	Provider of early stage clinical trial services	-	-	46/100
7th	Avance Clinical 2018, Thebarton (Australia), Late Stage	Provider of clinical development services	-	Riverside, Genesis Capital	43/100
8th	Aditum Bio 2019, Oakland (United States), Unfunded	CRO focused on clinical trial on phase II studies	-	-	42/100
9th	iCardiac Technologies 2006, Rochester (United States), Acquired	Company offering core laboratory services mainly for cardiac safety testing and respiratory diseases	$4M	Stonehenge Growth Equity Partners, Norwest ... & 4 others	41/100
10th	Unravel Biosciences 2020, Boston (United States), Seed	CRO offering early stage clinical development of drugs	$500K	BoxOne Ventures, Beresford Ventures	41/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on Altasciences's competitors? Click here to see the top ones

Altasciences has not made any investments yet. Altasciences has made 7 acquisitions.

Here is the list of latest three $acquisitions:

Filter this list

Date of Investment/Acquisition	Type	Company Name	Founded Year	Location
Jan 04, 2022	Acquisition	Sinclair Research	1964	Columbia (United States)
May 05, 2021	Acquisition	Calvert Labs	1969	Pennsylvania Furnace (United States)
Feb 19, 2021	Acquisition	Medelis WCCT Global	1998	Cypress (United States)